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Introduction
Genetic studies in yeast have identifi   ed a subset of vps 
(vacuolar protein–sorting) mutants, which are called the class 
E  mutants. These mutants display an exaggerated prevacuolar/late 
endosome compartment, called the class E compartment, which 
is caused by defects in multivesicular body (MVB) sorting 
(Raymond et al., 1992). There are 17 soluble and 1   membrane 
class E vps proteins in yeast, including Vps27p, the ESCRT-I, -II, 
and -III complexes, Vps4p, Bro1/Vps31, Vta1, Vps60p/MOS10, 
and Did2/Fti1 (Babst, 2005). A recent model has proposed 
that monoubiquitinated receptors and cargo proteins are fi  rst 
 recognized by Vps27p and Hse1p, which results in the  sequential 
  recruitment of three distinct multiprotein complexes, i.e., 
  ESCRT-I, -II, and -III, to endosomal membranes from the 
  cytosol (Katzmann et al., 2001; Babst et al., 2002a,b; Bilodeau 
et al., 2002). Although the details are unclear, these complexes 
are required for the sorting of monoubiquitinated cargo for 
  inclusion in MVBs, as well as the formation of the MVBs them-
selves (for reviews see Katzmann et al., 2002; Raiborg et al., 
2003). The fi  nal step in the membrane invagination that forms 
MVBs may be specifi   cally associated with the ESCRT-III 
  complex and its ability to interact with the AAA-ATPase Vps4p 
(Babst et al., 1998). Doa4p is a deubiquitinating enzyme that 
recycles ubiquitin by releasing monoubiquitin moieties before 
the incorporation of proteins into the internal membranes of the 
MVB (Amerik et al., 2000).
Several in vitro studies have investigated the protein– 
protein interactions of the class E Vps proteins in yeast and 
mammalian cells using yeast two-hybrid and GST pull-down 
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C
harged MVB protein 5 (CHMP5) is a coiled coil 
protein homologous to the yeast Vps60/Mos10 
gene and other ESCRT-III complex members, 
  although its precise function in either yeast or mammalian 
cells is unknown. We deleted the CHMP5 gene in mice, 
resulting in a phenotype of early embryonic lethality, 
  reﬂ   ecting defective late endosome function and dysre-
gulation of signal transduction. Chmp5
−/− cells exhibit 
  enlarged late endosomal compartments that contain 
abundant internal vesicles expressing proteins that are 
characteristic of late endosomes and lysosomes. This is in 
contrast to ESCRT-III mutants in yeast, which are defective 
in multivesicular body (MVB) formation. The degradative 
capacity of Chmp5
−/− cells was reduced, and undigested 
proteins from multiple pathways accumulated in enlarged 
MVBs that failed to trafﬁ  c their cargo to lysosomes. There-
fore, CHMP5 regulates late endosome function down-
stream of MVB formation, and the loss of CHMP5 enhances 
signal transduction by inhibiting lysosomal degradation 
of activated receptors.
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assays (Martin-Serrano et al., 2003; von Schwedler et al., 2003; 
Bowers et al., 2004). Through a coherent protein network, the 
ESCRT-I, -II, and -III complexes and associated proteins form 
a large MVB-sorting complex on endosomal membranes. The 
ESCRT-III complex is likely composed of two functionally 
distinct subcomplexes—a membrane-associated subcomplex 
(Vps20p–Snf7p) and a cytosolic subcomplex (Vps2p–Vps24p; 
Babst et al., 2002a). Recently, Did2/Fti1 and Vta1p were found 
to interact with Vps60p/MOS10, Vps4p, and the ESCRT-III 
complex, suggesting that together with Vps60p/MOS10 they 
play a role in regulating the activity of Vps4p and ESCRT-III 
(Bowers et al., 2004; Babst, 2005).
Several mammalian homologues of yeast Vps proteins 
have been identifi  ed (Katzmann et al., 2002). Many of these 
share common yeast homologues, implying a greater degree 
of complexity in the mammalian MVB-sorting pathway 
(von Schwedler et al., 2003). This may not be surprising, given 
the greater functional diversity and specialization that exists 
in   animal cells. Hrs is homologous to the yeast Vps27p and 
  re  cognizes ubiquitinated receptors through a conserved ubiquitin-
interacting motif (UIM), which is essential for MVB sorting to 
degradative pathways (Polo et al., 2002). Tsg101 is homolo-
gous to yeast Vps23p, which is an ESCRT I component, and 
down-regulates growth factor signaling through its interaction 
with Hrs (Babst et al., 2000; Lu et al., 2003). The AAA-ATPase 
SKD1 (Vps4B) is homologous to the yeast Vps4p and regulates 
the association/dissociation of the MVB-sorting complex in a 
manner that is dependent on its ATPase activity (Babst et al., 
1998; Yoshimori et al., 2000). Human Vps34 is a phosphoinosi-
tide 3 kinase that is required for internal vesicle formation 
within MVBs (Futter et al., 2001), and human Vps28 directly 
interacts with Tsg101 and is recruited to human Vps4 (E235Q)-
positive endosomal membranes (Bishop and Woodman, 2001). 
10 human charged MVB protein (CHMP) family proteins, 
which are structurally related cytosolic proteins containing 
coiled coil domains and are homologous to six yeast ESCRT-III 
components, have been identifi  ed. They have been suggested to 
play important roles in the fi  nal step of MVB-sorting pathways, 
namely the invagination of internal vesicles in MVBs, which is 
regulated by Vps4p (Babst, 2005). CHMP proteins also  function 
in HIV budding, a process that is topologically similar to MVB 
sorting (Martin-Serrano et al., 2003; von Schwedler et al., 
2003); however, the mechanism, function, and signifi  cance of 
CHMP proteins in mammalian MVB-sorting pathways remain 
to be defi  ned.
Results
CHMP5 is expressed ubiquitously 
and is essential for mouse embryogenesis
We originally isolated CHMP5 as a protein that copurifi  ed with 
cytosolic NF-κB–IκB complexes from rabbit lung extracts. 
  Microsequencing of this 32-kD copurifying protein revealed that 
it was identical to CHMP5, a CHMP family member and the 
mammalian homologue of yeast VPS60/MOS10 (Kranz et al., 
2001). Phylogenetic analyses indicate that CHMP5 is a unique 
CHMP protein that is quite divergent from other CHMP family 
proteins (unpublished data). We began our analysis of CHMP5 
by cloning and sequencing the murine and human cDNAs, 
which were obtained by screening a mouse liver cDNA library 
and by PCR from HeLa cell cDNA, respectively. CHMP5 is 
highly conserved through evolution and its homologues can be 
found in Drosophila melanogaster,  Caenorhabditis elegans, 
Arabidopsis thaliana, and yeast (Fig. 1 a).  [ID]FIG1[/ID] CHMP5 is also 
ubiquitously expressed in embryonic and adult mouse tissues 
(not depicted and Fig. 1 b, respectively).
Figure 1.  Characterization of CHMP5. (a) Protein sequence alignment of CHMP5 homologues from mouse, human, D. melanogaster, C. elegans, A. thaliana, 
and yeast. (b) Northern blot analysis of adult mouse tissues.CHMP5 IS ESSENTIAL FOR LATE ENDOCYTIC TRAFFICKING • SHIM ET AL. 1047
Although the biological signifi  cance of the association of 
CHMP5 with the NF-κB–IκB complex remains unclear, we 
decided to explore the biological function of CHMP5 by 
generating Chmp5
−/− mice. Chmp5 genomic DNA (29.8 kb) was 
isolated from a 129/SvJ murine genomic DNA library   using 
Chmp5 cDNA as a probe. The Chmp5 gene contains eight small 
exons and is separated by only 414 bp from the Bag1 gene 
(Takayama and Reed, 2001). These two genes are encoded by 
different DNA strands, and their 5′ ends are positioned head-
to-head (Fig. 2 a).  [ID]FIG2[/ID] To generate a null mutation of Chmp5, 
  exons 3–7 of the Chmp5 gene were replaced by a loxP-fl  anked 
neomycin-resistant gene cassette. After homologous recombi-
nation, the neo gene was deleted by crossing Chmp5
+/− mice 
with Splicer mice (Fig. 2 b; Koni et al., 2001). The resulting 
heterozygous mice were phenotypically normal, but the homo-
zygous mice died at approximately embryonic day 10 (E10). 
Most wild-type embryos and mutant littermates did not exhibit 
any gross morphological difference until E7.5, after which the 
  mutant embryos displayed severe developmental abnormalities 
in the ventral region (Fig. 3 a).  [ID]FIG3[/ID] At E8.75, mutant embryos were 
severely disorganized, with abnormal neural tube formation, 
allantois-chorion fusion, and somite segmentation, although 
  embryonic axes and structures are normal in mutant embryos 
(Fig. 3 b). To further analyze the anatomy of Chmp5
−/− embry-
onic structure, we performed histological analysis of E8.5 wild-
type embryos and mutant littermates (Fig. 3 c). Consistent with 
Fig. 3 b, severe developmental abnormalities of allantois, head 
fold, heart, and somite, and an apparent defect of ventral folding 
morphogenesis, were detected in the mutant embryos. To char-
acterize the mutant phenotype, we performed whole-mount in 
situ hybridization with Nkx2.5 as a marker of heart formation 
(Fig. 3 d, top) and TUNEL assay to assess cell death in E8.5 mutant 
embryos (Fig. 3 d, bottom). Remarkably, mutant embryos ex-
hibited the formation of two independent hearts (cardia bifi  da), 
accompanied by massive cell death in the ventral region. These 
phenotypes are similar to those of murine and D. melanogaster
embryos lacking Hrs (Table I; Komada and Soriano, 1999; Lloyd 
et al., 2002).  [ID]TBL1[/ID]These fi  ndings suggest that CHMP5, like Hrs, may 
play a role in regulating the endocytosis or lysosomal transport 
of receptors involved in signal transduction and, therefore, is 
indispensable for early   embryonic development. However, a 
role for a putative ESCRT-III complex in receptor traffi  cking in 
mammalian cells is yet to be demonstrated.
CHMP5 is required for lysosomal 
biogenesis from late endosomes
To evaluate the involvement of CHMP5 in endocytosis, we 
  isolated and cultured primary embryonic cells derived from 
E8.5 Chmp5
−/− embryos. Phase-contrast microscopy indicated 
that Chmp5
−/− cells contained enlarged vacuole-like structures 
(Fig. 4 a), a phenotype similar to Hrs
−/− primary embryonic 
cells (Komada and Soriano, 1999). To characterize these struc-
tures, we performed immunofl  uorescence analysis with markers 
specifi  c for different subcellular compartments. Immunostain-
ing with transferrin receptor (early and recycling endosomes), 
EEA1 (early endosomes), TGN38 (trans-Golgi network), and 
Rab8 (recycling endosomes and trans-Golgi network) did not 
reveal any gross differences between wild-type and mutant cells 
(Fig. 4 a and not depicted). Further coimmunostaining with 
markers specifi  c for late endosomes-MVBs and/or lysosomes, 
cation-independent mannose 6-phosphate receptor (M6PR; 
CI-M6PR), lysobisphosphatidic acid (LBPA), and lysosome-
associated membrane protein 1 (LAMP1), demonstrated that 
Figure 2.  Generation of Chmp5
−/− embryos. (a and b) Targeting of the 
Chmp5 gene and analysis of ES clones. The targeting vector is described 
in Materials and methods. Note that the ﬁ  rst two exons of the Bag1 gene 
are represented by two horizontally lined boxes. Genomic DNA was di-
gested with XbaI or BamHI and hybridized with probe B or A, respectively. 
The hybridized DNA fragments were 19 kb (XbaI) and 6.1 kb (BamHI) for 
the wild-type allele and 14 kb (XbaI) and 4.5 kb (BamHI) for the targeted 
allele. (c) Wild-type (+/+) and mutant (−/−) ES cell lysates were immuno-
blotted with antibodies speciﬁ  c for CHMP5 and GAPDH4.
Table I. Comparison of the phenotypes between Chmp5 and Hrs 
mutant embryos
Chmp5
−/− Hrs
−/−
Early embryonic lethality around E10
Most mutant embryos are smaller than the wild types at E7.5
Defect in ventral fording morphogenesis
Cardia biﬁ  da and massive cell death in ventral region around E8.5
No fusion of allantois with chorion
No somite segmentation
Enlarged M6PR and LAMP1-positive 
endosomal compartments
Enlarged TfR-positive endosomal 
compartments
Enlarged MVBs result from heavily 
packed internal vesicles
Enlarged MVBs result from defect 
of vesicular invaginationJCB • VOLUME 172 • NUMBER 7 • 2006  1048
the vacuoles visible by phase contrast in Chmp5
−/− cells were 
positive for CI-M6PR, LBPA, and LAMP1 (Fig. 4, b and c). 
Indeed, the degree of colocalization was far more pronounced 
in the mutant cells as compared with wild-type cells in which, as 
expected, distributions of CI-M6PR and LAMP1 and LBPA and
LAMP1 overlapped only partially. Structures positive for CI-
M6PR and lgp/LAMP1 or for LBPA and LAMP1 are generally 
defi  ned as being late endosomes and as distinct from lysosomes 
which do not contain appreciable levels of CI-M6PR and LBPA 
(Kornfeld and Mellman, 1989; Kobayashi et al., 1998; Luzio 
et al., 2000). Thus, CHMP5 defi  ciency was accompanied by
an accumulation of structures that appear to be late endosomes. 
To examine a distinct MVB-sorting pathway in Chmp5
−/− 
cells, we performed immunostaining for major histocom-
patibility class (MHC) II. The majority of newly synthesized 
MHC II molecules are diverted from the secretory pathway 
upon exit from the trans-Golgi network and are directly tar-
geted to endosomes/lysosomes (Mellman and Steinman, 2001). 
Mouse embryonic fi  broblasts (MEFs) derived from E9.0 wild-
type   embryos were stimulated with IFN-γ to induce MHC II 
expression (Fig. 4 d; Ilangumaran et al., 2002). Wild-type and 
Chmp5
−/− MEFs, stimulated with IFN-γ, were then stained with 
anti-MHC II (I-Aβ) antibody (Fig. 4 e). Chmp5
−/− cells exhibit 
enlarged endosomes positive for MHC II molecules, whereas 
MHC II–positive endosomes are scattered throughout the periph-
eral cytoplasm in wild-type cells. Thus, CHMP5 defi  ciency led to 
the accumulation of MHC II–positive endosomes/lysosomes.
We then used transmission electron microscopy to examine 
MVBs in wild-type and mutant embryos. Strikingly, MVBs in 
the endodermal cells from the mutant embryos were abnormally 
enlarged and heavily packed with internal vesicles and electron-
dense content, as compared with the analogous structures in 
cells from wild-type embryos (Fig. 4 f). Stereological analysis 
revealed that the fraction of total cell volume occupied by 
MVBs in Chmp5
−/− cells was  1.5-fold that in wild-type cells 
(Fig. 4 g), confi  rming quantitatively that the endosomes were 
enlarged in the mutant cells. Interestingly, this phenotype was 
most clearly manifested in endodermal cells, where endo-
cytosis is most active during embryogenesis. Collectively, these 
  observations suggest that CHMP5 defi  ciency caused a global 
disruption in protein sorting to, or the formation of, lyso-
somes (M6PR
−/LBPA
−/LAMP1
+) from late endosomes/MVBs 
(M6PR
+/LBPA
+/LAMP1
+), rather than a specifi  c defi  cit in the 
sorting of select proteins into lysosomes. Surprisingly, although 
CHMP5 defi  ciency affected the ability of target proteins to 
 traffi  c to lysosomes, it did not prevent MVB formation.
To determine whether the block in the formation of 
  lysosomes positive for M6PR
−/LBPA
−/LAMP1
+ would result 
Figure 3.  Abnormal development of Chmp5 
mutant embryos. (a) Morphological analysis 
of  Chmp5 mutant embryos. Lateral view of 
wild-type (+/+) embryos and mutant (−/−) 
littermates at E7.5, E7.75, E8.5, and E9.25. 
(b) Lateral, front, and ventral view of E8.75 
Chmp5 mutant embryos. The yolk sac was 
  removed from the embryos. Al, allantois; Am, 
amnion; Hf, head fold; M, midline. (c) Histo-
logical analysis of E8.5 Chmp5 mutant 
  embryos. Ht, heart; S, somite. (d) Abnormal 
heart formation in Chmp5 mutant embryos re-
vealed by whole-mount in situ hybridization 
with the cardiac marker Nkx2.5. (top) Arrows 
and arrowhead indicate heart tissue. Massive 
cell death in Chmp5 mutant embryos revealed 
by TUNEL staining of E8.5 embryos. (bottom) 
  Arrow indicates apoptotic cells. Bars: (c) 50 μm; 
(d) 100 μm.CHMP5 IS ESSENTIAL FOR LATE ENDOCYTIC TRAFFICKING • SHIM ET AL. 1049
in impaired degradative capacity in Chmp5
−/− cells, we  derived 
Chmp5
−/− embryonic stem (ES) cells from the inner cell mass 
of blastocysts obtained by breeding Chmp5 heterozygotes. 
ES cells are equivalent to E3.5 embryonic cells and the Chmp5 
  mutant phenotype was therefore less dramatic in ES cells than 
in E8.5 embryonic cells. Both wild-type and mutant ES cells 
were able to internalize FITC-conjugated dextran at similar 
rates (unpublished data), indicating that CHMP5 was not 
  required for fl   uid phase endocytosis by itself. However, 
Chmp5
−/− ES cells exhibited a greatly reduced capacity to 
  degrade material after internalization. After a 1-h pulse of the 
fl  uid phase marker HRP, wild-type ES cells degraded nearly all 
of the internalized protein after 9 h of chase. In contrast, very 
little of the HRP was degraded after uptake by Chmp5
−/− ES 
cells, as determined by immunoblotting (Fig. 5 a) and fl  ow 
  cytometry (Fig. 5 b).  [ID]FIG5[/ID]Moreover, immunogold labeling of inter-
nalized HRP revealed that approximately fi  vefold more inter-
nalized HRP   accumulated within enlarged MVBs in Chmp5
−/− 
ES cells than in wild-type cells (Fig. 5 c). Thus, although HRP 
reached   canonical late endosomes/MVBs, it was degraded less 
effectively in the   absence of CHMP5.
Defective degradation of lysosomal contents could  refl  ect 
either a disruption in the transport of internalized proteins to 
  lysosomes or a lower overall proteolytic capacity. Immuno-
blotting of ES cell lysates with antibodies specifi  c for cathepsin 
D and L revealed that they were present in equivalent amounts 
in wild-type and Chmp5
−/− ES cells (Fig. 5 d). Thus, it 
  appeared more likely that the defective degradative phenotype 
refl  ected  ineffi   cient delivery of endocytosed proteins to 
  compartments containing active lysosomal hydrolases. Such a 
  defect might also affect the normal down-regulation of signaling 
receptors, suggesting that the embryonic lethality of Chmp5 
deletion might refl  ect hyperactive signal transduction. There-
fore, we examined the dynamics of TGFβ receptor II (TβRII), 
which has a well characterized role in early embryogenesis 
(Seto et al., 2002).
CHMP5 affects turnover 
and down-regulation of TGF𝗃 receptors
The early embryonic lethality of Chmp5 mutant embryos 
  prevented us from obtaining appropriate mutant cells that could 
be used to study receptor turnover and signaling in vitro. 
We therefore used small interfering RNA (siRNA) technology 
to generate CHMP5 knockdown cells. Two target sequences of 
the Chmp5 gene (Sh1 and Sh2; murine CHMP5) were cloned 
into a pSUPER.retro vector along with an H1-RNA promoter, 
Figure 4.  CHMP5 is essential for biogenesis of lysosomes from mature MVBs. (a–c) Immunoﬂ  uorescence analysis of Chmp5
−/− primary embryonic cells. 
Transferrin receptor (TfR), CA-MPR, LBPA, and LAMP1 are markers for early endosome, late endosome/MVB, and MVB/lysosome, respectively. Arrowheads 
indicate phase-lucent vacuolar structures present in the Chmp5
−/− cells. (d) Induction of MHC II expression by IFN-γ. Primary cells derived from E9.0 embryos 
were incubated with the indicated amount of IFN-γ for 48 h (top) or incubated with 1 μg IFN-γ for the indicated time points (bottom). Expression of MHC II 
molecules was analyzed by immunoblotting with anti-MHC II (I-Aβ) antibody. (e) Wild-type or Chmp5
−/− primary embryonic cells were stained with anti-
MHC II (I-Aβ) antibody. (f) Transmission electron microscopy analysis of MVBs in the endodermal cells of E8.25 embryos. The inset shows an internal vesicle. 
(g) The fraction of MVBs per total cell volume was measured in endodermal layer of wild-type embryos (+/+) and mutant (−/−) littermates. Approximately 
120 MVBs from the sections of six wild-type or Chmp5
−/− embryos were counted. Error bars represent the SD. Bars: (a–c and e) 10 μm; (f) 500 nm.JCB • VOLUME 172 • NUMBER 7 • 2006  1050
which directs synthesis of short hairpin RNA (shRNA) that can 
be converted into an siRNA capable of knocking down target 
gene expression (Paddison et al., 2002). Transient transfection 
of the shRNAs showed that Sh2 was capable of dramatically 
  reducing the level of transiently expressed mouse CHMP5, 
whereas Sh1 was inactive in this assay.
To determine if CHMP5 defi  ciency affects the postendo-
cytic fate of TβRII, we transfected NIH3T3 cells with HA-
tagged TβRII (HA-TβRII) in the absence or presence of Sh2 
(Fig. 6 a). [ID]FIG6[/ID] Receptor endocytosis was triggered by the addition 
of TGFβ, and receptor fate was monitored using an anti-HA 
monoclonal antibody that was added simultaneously to the 
 medium, as previously described (Hayes et al., 2002; Di Guglielmo 
et al., 2003). Receptor distribution was analyzed relative 
to LAMP1 staining. In control cells, HA-TβRII was found 
largely in LAMP1-negative endosomes scattered throughout 
the   peripheral cytoplasm, refl  ecting internalization of the recep-
tor and its degradation in lysosomes. In CHMP5 knockdown 
cells, however, TβRII was more abundant and was often associ-
ated with enlarged, LAMP1-positive structures typical of the 
 enlarged late endosomes/MVBs seen in Chmp5
−/− cells. At least 
at the level of immunofl  uorescence, the receptor appeared to 
  reside within the endosomal lumen as well as on the limiting 
membrane. Consistent with this, a recent report has also shown 
that GFP-tagged CHMP5 protein, which is a putative CHMP5 
dominant-negative mutant, leads to accumulation of ligand-
bound EGF receptor (EGFR) in enlarged perinuclear vesicles 
and a delay in EGFR degradation (Ward et al., 2005).
To determine localization of TβRII in these endosomes, we 
performed a protease protection assay on subcellular fractions 
Figure 5.  CHMP5 plays a role in endosomal transport to lysosomes. (a and b) HRP degradation is blocked in Chmp5
−/− cells. ES cells cultured on 0.2% 
gelatin-coated plates were incubated in medium containing 100 μg/ml HRP for 1 h and then placed in normal medium (time 0). (a) Cells were lysed at the 
indicated time points and immunoblotted with anti-HRP antibody. (b) Alternatively, the amount of HRP remaining inside the cells was quantitatively measured 
by ﬂ  ow cytometry, and the percentage of cellular HRP was calculated based on mean ﬂ  uorescence intensity. (c) Transmission electron microscopy analysis 
of internalized HRP in MVBs of Chmp5
−/− cells. After incubation with HRP for 2 h, ES cells were ﬁ  xed, sectioned, and stained with gold-conjugated anti-HRP 
antibody. Arrowheads indicate HRP-gold particles. (d) Lysosomal hydrolase activity in Chmp5
−/− cells. Wild-type (+/+; 1) and mutant (−/−; 2 and 3) 
ES cells were lysed and immunoblotted with antibodies speciﬁ  c to cathepsin D and L. Bar, 100 nm.CHMP5 IS ESSENTIAL FOR LATE ENDOCYTIC TRAFFICKING • SHIM ET AL. 1051
of cells expressing COOH-terminal HA-TβRII along with control 
vector or human CHMP5 shRNA (Sh3; Fig. 6 b). Percoll gradi-
ents allowed a separation of a light fraction containing the plasma 
membrane, early/recycling endosomes, and a population of 
Rab7
+ or LAMP1
+ endosomes from denser fractions containing 
Rab7
+ late endosomes, as well as LAMP1
+ lysosomes  (Mellman, 
1996). In control cells, the majority of the HA-TβRII was, as 
  expected, detected in the light fraction (i.e., at the plasma mem-
brane) in the absence of TGFβ stimulation. After TGFβ   addition 
for 5 h, the total amount of receptor was greatly decreased 
  because of degradation, but some of the remaining HA-TβRII 
was   detected in the dense fractions, consistent with ligand-
  induced internalization and delivery to lysosomes. The majority 
of HA-TβRII, particularly in the light-density plasma membrane– 
containing fractions, was sensitive to proteinase K treatment.
A different picture emerged in cells lacking CHMP5. First, 
consistent with our analysis of steady-state (Fig. 6 d) and cell 
surface expression (Fig. 6 e) of TβRII receptors, HA-TβRII 
levels were signifi  cantly increased in CHMP5 knockdown cells. 
Importantly, after TGFβ treatment the HA-TβRII that appeared 
in the denser fractions was now protected from degradation 
by proteinase K. Thus, at least a portion of the HA-TβRII that 
  accumulates after ligand-induced receptor internalization 
  appears to be localized within the lumen of Percoll-dense 
  compartments, likely MVBs. Together with our morphological 
experiments, these data suggest that CHMP5 defi  ciency leads to 
the accumulation of internalized TβRII, at least, in part, on the 
internal membranes of late endosomal MVBs.
The increased staining of the HA-TβRII suggested that 
CHMP5 knockdown interfered with the normal down-regulation 
Figure 6.  CHMP5 plays a role in down-regulation of TGF𝗃 receptors. (a) Subcellular distribution of TβRII in CHMP5 knockdown cells. NIH3T3 cells were 
transfected with extracellularly HA-TβRII in the absence or presence of murine CHMP5 shRNA (Sh2). 48 h later, cells were incubated with HA antibody, 
stimulated with 5 ng/ml TGFβ for 1 h, and immunostained with anti-LAMP1 antibody. (b) HEK293 cells were transfected with COOH-terminal HA-TβRII in 
the absence or presence of human CHMP5 shRNA (Sh3). 48 h after transfection, cells were treated with 10 ng/ml TGFβ for 5 h or left untreated, and frac-
tionated on Percoll gradients. Transferrin receptor (TfR), Rab7, or LAMP1 was used as a marker for the plasma membrane, early or recycling endosomes, 
late endosomes/MVBs, or lysosomes, respectively. Each fraction was treated with proteinase K or left untreated, and HA-TβRII was analyzed by immuno-
blotting with anti-HA antibody. (c) NIH3T3 cells were transfected with TβRII-HA, together with control vector or murine CHMP5 shRNA (Sh2). 48 h later, cells 
were labeled with S
35 methionine in the absence or presence of 0.4 mM chloroquine, and then chased for the indicated times in medium containing unla-
beled methionine and 5 ng/ml TGFβ. S
35-labeled TβRII was immunoprecipitated with anti-HA antibody, and then analyzed by phosphorimaging. Alterna-
tively, the HA-TβRII expression was quantiﬁ  ed and graphed as receptor quantity (percentage of time 0) versus time. (d) HEK293 cells were transfected with 
control vector (Vector), CHMP5 expression vector (CHMP5), or human CHMP5 shRNAs (Sh3) and immunoblotted with antibodies speciﬁ  c to CHMP5 and 
GAPDH4 (top). HEK293 cells were transfected with TβRI-HA and TβRII-HA, together with control vector, CHMP5, or CHMP5-Sh3. 48 h after transfection, 
cells were treated with 10 ng/ml TGFβ for 5 h, or left untreated in the presence of 20 μM cyclohexamide before lysis, and then immunoblotted with anti-
bodies speciﬁ  c to HA and GAPDH4. (e) HEK293 cells were transfected with extracellularly HA-TβRII, together with control vector or human CHMP5 shRNA 
(Sh3). 48 h after transfection, HA-TβRII expression was analyzed with anti-HA antibody by using ﬂ  ow cytometry. (f) NIH3T3 cells were incubated with 
  biotin-conjugated HRP in medium containing protease inhibitors for 3 h to label preexisting lysosomes. 48 h after transfection with murine CHMP5 shRNAs 
(Sh1 and Sh2), cells were incubated with streptavidin for 10 min, washed, and chased for the indicated time. Cells were lysed with biotin-containing lysis 
buffer and HRP enzymatic activity was measured using ELISA on anti–streptavidin-coated plates. Endogenous murine CHMP5 protein level was analyzed 
by immunoblotting with anti-CHMP5 antibody (top). Error bars represent the SD. n = 3.JCB • VOLUME 172 • NUMBER 7 • 2006  1052
of the receptor after ligand binding. To test this hypothesis, we 
transfected NIH3T3 cells with HA-TβRII, together with   either 
control vector or Sh2, and assessed receptor turnover   using 
pulse-chase analysis (Fig. 6 c). Consistent with a previous 
study showing that chloroquine signifi  cantly increases the sta-
bilization of endogenous TGFβ receptors (Kavsak et al., 2000), 
treatment of cells with chloroquine blocked degradation of 
HA-TβRΙΙ receptors in cells expressing either control vector or 
mouse Sh2. In cells expressing the control vector, the half-life 
of HA-TβRΙΙ receptors was  1.5 h, whereas in cells where 
CHMP5 was knocked down, the half-life was extended to  3.5 h. 
To further characterize the effect of CHMP5 expression on 
TGFβ receptor turnover, we determined receptor levels in 
  human embryonic kidney 293 (HEK293) cells that had been 
transfected with vectors encoding either wild-type CHMP5 or 
Sh3. The resulting cells slightly overexpressed or dramatically 
diminished the expression of CHMP5 protein, respectively 
(Fig. 6 d). Consistent with the decreased rate of degradation in 
NIH3T3 cells, knockdown of CHMP5 greatly increased the 
steady-state levels of both TβRI and TβRII (Fig. 6 d, bottom). 
In contrast, overexpression of CHMP5 slightly decreased the 
amount of receptor protein, relative to nontransfected controls. 
Similarly, using fl  ow cytometry we found that CHMP5 knock-
down signifi  cantly increased steady-state levels of HA-TβRΙΙ 
receptors on the cell surface, relative to the control vector 
(Fig. 6 e). Together, these fi  ndings suggest that the loss of 
CHMP5 slows the degradation of internalized TGFβ receptors 
by   preventing ligand-induced down-regulation. Like internal-
ized HRP, the receptors accumulated intracellularly in late en-
dosomes/MVBs, which are structures normally associated with 
receptor degradation.
To investigate whether the defect in receptor degradation 
might refl  ect a failure of late endosomes/MVBs to fuse with 
preexisting lysosomes, we performed an endosome–lysosome 
fusion assay using shRNA to transiently knockdown CHMP5 
expression. To label preexisting lysosomes, NIH3T3 cells 
  pretreated with protease inhibitors were incubated with biotin-
conjugated HRP (biotin-HRP) for 3 h, and then transfected 
with Sh2. 48 h later, the cells were incubated with streptavidin 
for 10 min, and the formation of streptavidin–biotin-HRP 
  complexes was determined after various chase intervals. Vector 
and control shRNA (Sh1)–expressing cells showed increasing 
complex formation over time, whereas complex formation 
was dramatically inhibited in Sh2-expressing cells (Fig. 6 f). 
Figure 7.  CHMP5 regulates multiple signaling pathways. (a) Hyperactivation of multiple signaling pathways in Chmp5
−/− embryos. Extracts from E8.5 
wild-type (+/+) and mutant (−/−) embryos were immunoblotted with antibodies speciﬁ  c to phosphotyrosine (pY), phospho-Erk1/2 (P-Erk1/2), phospho-
Smad2 (P-Smad2), Smad2, Smad4, and GAPDH4. (b) Nuclear localization of phosphorylated Smad2 in Chmp5
−/− primary embryonic cells. Wild-type 
(+/+) and Chmp5
−/− (−/−) cells were stained with anti–phospho-Smad2 antibody. Images were obtained by a ﬂ  uorescence microscope using a 40× 
objective. (c) NMuMg cells were transfected with the 3TP-lux reporter together with the indicated amounts of CHMP5 expression vector. Cells were treated 
with 1 ng/ml TGFβ for 24 h before lysis and then analyzed for luciferase activity. (d) NMuMG cells were transfected with murine CHMP5 shRNAs (Sh2 
and Sh1) or control vector (Vector) and assayed as in c. Endogenous CHMP5 protein level was analyzed by immunoblotting with anti-CHMP5 antibody. 
(e and f) Distributions of TβRII and SARA in Chmp5
−/− primary embryonic cells. Wild-type (+/+) and Chmp5
−/− (−/−) cells were stained with antibodies 
speciﬁ  c for TβRII (e) and SARA (f). (g) HEK293 cells were transfected with pBIIX-luc reporter together with the indicated amounts of CHMP5 expression 
  vector. Cells were treated with 10 ng/ml TNFα or10 ng/ml IL-1β for 4 h before lysis and then analyzed for luciferase activity. Alternatively, cells were 
  transfected with pBIIX-luc reporter, CD4-TLR4 expression vector, and the indicated amounts of CHMP5 expression vector. Luciferase activity was assayed 
24 h after transfection. (c, d, and g) Error bars represent the SD. n = 3. Bars, 20 μm.CHMP5 IS ESSENTIAL FOR LATE ENDOCYTIC TRAFFICKING • SHIM ET AL. 1053
Therefore, streptavidin cannot easily reach previously formed 
lysosomes in the absence of CHMP5, implying that CHMP5 is 
required for efficient fusion of late endosomes/MVBs with 
preexisting lysosomes.
CHMP5 down-regulates multiple signaling 
pathways during mouse embryogenesis
If, in fact, an alteration in receptor traffi  cking or degradation is 
responsible for the developmental phenotype associated with 
CHMP5 deletion, one would expect that knockout embryos 
would exhibit defects in TGFβ receptor signal transduction. 
There is evidence that TGFβ receptor signaling is regulated by 
endocytosis, with internalization being required for the receptor 
to reach an essential adaptor component, Smad anchor for 
  receptor activation (SARA), in EEA1-positive endosomes, and 
to be subject to normal degradation and down-regulation after 
signal transmission (Hayes et al., 2002; Seto et al., 2002; 
Di Guglielmo et al., 2003). Moreover, signaling by FGF and 
TGFβ family members plays an essential role in embryogenesis 
at the stage when CHMP5 defi  ciency causes lethality (Rossant 
et al., 1997; Corson et al., 2003).
We investigated the activation state of these signaling 
pathways in Chmp5
−/− embryos by examining the phosphoryla-
tion status of relevant signaling proteins. We made whole cell 
lysates from E8.5 wild-type and Chmp5
−/− embryos and immuno-
blotted these extracts with phosphospecifi  c antibodies against 
different proteins that are phosphorylated upon signaling. 
As shown in Fig. 7 a, tyrosine phosphorylation of many  proteins, 
including Erk1/2 and Smad2, which function in growth factor 
and TGFβ family member signaling, respectively, was signi-
fi  cantly enhanced in Chmp5
−/− embryos.  [ID]FIG7[/ID] In addition, phosp-
horylated Smad2 was primarily localized in the nucleus of 
Chmp5
−/− cells, unlike wild-type cells in which phosphory-
lated Smad2 is rarely observed (Fig. 7 b). These   results sug-
gest that signaling by growth factors and TGFβ family members 
is hyperactivated in Chmp5
−/− embryos and it is likely that such 
dysregulation leads to embryonic lethality. Consistent with this 
hypothesis, TGFβ-mediated gene induction is signifi  cantly in-
hibited by CHMP5 overexpression and is increased upon 
CHMP5 knockdown (Fig. 7, c and d). We hypothesized that 
CHMP5 defi  ciency may facilitate recycling of TGFβ receptors 
to the plasma membrane by inhibiting lysosomal degradation of 
receptor, thereby leading to enhanced TGFβ signaling in 
Chmp5
−/− cells. To test this hypothesis, we examined the distri-
bution of TGFβ receptor and its signaling adaptor SARA in 
Chmp5
−/− cells. Immunostaining analysis with antibodies 
 specifi  c for TβRII and SARA revealed that both TβRII and 
SARA accumulated on the plasma membrane of Chmp5
−/− 
cells,   although TβRII and SARA are relatively enriched in the 
TGN and cytosol of wild-type cells (Fig. 7, e and f). This is 
consistent with fl   ow cytometric analyses, which indicated 
CHMP5 knockdown increases cell surface expression of HA-
TβRII, relative to control (Fig. 6 e). Therefore, these results 
suggest that CHMP5 defi  ciency increases the steady-state levels 
of TGFβ receptor expression at the cell surface by decreasing 
degradation of internalized receptors. Increased cell surface 
 expression  of  TGFβ receptor and its association with the key 
signaling adaptor SARA appears to be responsible for enhanced 
TGFβ signaling in Chmp5
−/− cells.
We further demonstrated a generalized role for CHMP5 
in down-regulation of receptor signaling pathways by monitor-
ing NF-κB activity. The early lethality of Chmp5
−/− embryos, 
and the inability to generate knockout mouse embryonic 
fi  broblasts prevented us from assaying NF-κB activation in 
the knockout cells themselves. Therefore, we tested the role 
of CHMP5 in NF-κB activation in cell lines using a   reporter 
assay system. As shown in Fig. 7 g, CHMP5 overexpres-
sion inhibits NF-κB activation induced by the infl  ammatory 
 cytokines  TNFα and IL-1β, as well as CD4-TLR4, a domi-
nant active chimera of the toll-like receptor for the bacterial 
component lipopolysaccharide (Hayden and Ghosh, 2004). 
This result suggests that, similar to growth factor and TGFβ 
signaling, signaling to NF-κB is also regulated by endocytosis 
and, hence, that CHMP5 plays a role in the down-regulation of 
multiple signaling pathways.
Discussion
This study demonstrates that CHMP5 is essential for the fi  nal 
step of MVB sorting, namely the maturation of late endosomes/
MVBs into lysosomes. In contrast to the related members of 
the yeast ESCRT-III complex, which are thought to be required 
for MVB formation, CHMP5 appears to be dispensable in this 
 process;  CHMP5-defi  cient cells contain abundant, and, indeed, 
  enlarged, late endosomal MVBs. Instead, CHMP5 defi  ciency 
was associated with a signifi  cant reduction in degradative ca-
pacity, with a resulting accumulation of cargo proteins in en-
larged MVBs. We also found that CHMP5 defi  ciency induces a 
generalized up-regulation of multiple signaling pathways that is 
attributable to the lack of degradation of internalized receptors. 
The resulting hyperactivation of growth factor–mediated sig-
naling is likely responsible for the observed early embryonic 
 lethality  of  Chmp5
−/− mice.
A role for CHMP5 in late 
endocytic trafﬁ  cking
The fact that CHMP5 was not required for MVB formation 
probably does not imply a fundamental difference between the 
ESCRT-III complexes in yeast and animal cells. Instead, it 
seems more likely that CHMP5 may not be a key component of 
the ESCRT-III complex in MVB formation. Indeed, previous in 
vitro studies have found that yeast Vps60p/MOS10, the closest 
yeast homologue to mammalian CHMP5, associates with the 
class E Vps protein, Vta1p, but not with the key ESCRT-III pro-
teins (Bowers et al., 2004; Shifl  ett et al., 2004). Vps60p/MOS10 
is, however, closely related to ESCRT-III proteins by amino acid 
sequence and by function, as Vps60p/MOS10 mutants   exhibit 
a class E vacuolar phenotype (Kranz et al., 2001). Whether 
Vps60p/MOS10 is required for MVB formation in yeast is not 
clear, nor is its actual function in the vacuolar pathway.
Although not essential for cell viability, deletion of 
CHMP5 in mice was found to be required for normal embry-
onic development, indicating that this gene plays an important 
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  deletion (or knockdown) did cause a marked phenotype 
(i.e., the accumulation of an expanded late endosomal MVB 
compartment) the failure to deliver internalized content to lyso-
somes, and the reduced degradation of internalized cargo pro-
teins and receptors. Although MVB formation appeared   intact 
in CHMP5 knockout cells, there was a nonspecifi  c defect in the 
transport of multiple proteins, including fl  uid phase markers, 
MHC II, and cell surface receptors, to lysosomes. As a result, 
CHMP5 function seems necessary for complete MVB sorting, 
as it is responsible for the fi  nal conversion of late endosomal 
MVBs to lysosomes, rather than for the formation of MVBs 
themselves. Thus, CHMP5 may affect any of several possible 
events, including delivery of lysosomal enzymes to late endo-
somes, recycling of late endosomal components, or the fusion 
of late endosomes with hydrolase-rich lysosomes. Our data 
  favor the latter possibility because we found that the rate of 
  delivery of newly internalized streptavidin to lysosomal com-
partments containing previously internalized biotin-HRP was 
greatly slowed by CHMP5 depletion (Fig. 6 f).
Whatever its precise role, it is clear that CHMP5 is an im-
portant element in late endosomal function. Remarkably little 
is known about this protein, however. As indicated by phyloge-
netic analysis, CHMP5 (Vps60p/MOS10) is a unique CHMP 
family protein that does not belong to any subfamily of CHMP 
proteins. Conceivably, it may play roles beyond those described 
here for the endocytic pathway. The 5′ end of the Chmp5 gene 
is separated by only 414 bp from opposing strands of the Bag1 
gene (Takayama and Reed, 2001), suggesting that both may be 
coregulated at the transcriptional level. BAG-1 is clearly in-
volved in modulating apoptosis, cell proliferation, transcription,
and cell motility as a multifunctional regulator. This implies the 
possibility that CHMP5 may participate in functions modu-
lated by BAG1. In this regard, it is also interesting to note that 
Vps60p/MOS10 is required for the fi  lament maturation of 
  Sacchoromyces cerevisiae by targeting specifi  c cargo proteins 
for degradation, whereas the yeast ESCRT-III proteins are 
  required for early pseudohyphal growth (Kohler, 2003). We also 
found that CHMP5 is required for recruitment of CHMP1A (the 
mammalian homologue of the yeast Did2/Fti1) to endosomal 
  membranes, where CHMP5 may complete an ESCRT-III 
  complex formation (unpublished data). Failure of these fi  nal 
  recruitment events may prevent the newly formed MVBs from 
releasing the assembled ESCRT complexes, impeding subsequent 
maturation of the MVBs themselves.
A role for CHMP5 in the regulation 
of signaling pathways during 
mouse embryogenesis
It is well established that degradation of cell surface receptors 
through endocytosis is a common mechanism of down-regulating 
growth factor and TGFβ receptor signaling (Katzmann et al., 
2002; Seto et al., 2002). Genetic studies in D. melanogaster 
have reported that deletion of Hrs caused a defect in degrada-
tion of activated receptor tyrosine kinases, leading to enhanced 
tyrosine kinase signaling (Lloyd et al., 2002). However, despite 
the importance of the MVB-sorting pathway in receptor down-
regulation, relatively little is known about the functional roles 
of mammalian endocytic components other than Hrs and 
Tsg101. Early embryonic lethality in mutant embryos has hin-
dered genetic studies of mammalian endocytic components 
(Komada and Soriano, 1999; Ruland et al., 2001). Our results 
indicate that CHMP5 is required for down-regulation of TGFβ 
signaling pathways through lysosomal degradation of internal-
ized receptors, which is consistent with in vivo results that show 
signaling by growth factors and TGFβ family members is 
 hyperactivated  in  Chmp5
−/− embryos. Indeed, Chmp5
−/− cells 
exhibit increased steady-state levels of TGFβ receptor expres-
sion and accumulation of an essential TGFβ signaling adaptor, 
SARA, perhaps suggesting that CHMP5 deletion facilitates 
 recycling of TGFβ receptors to the plasma membrane by blocking 
receptor degradation in lysosomes. CHMP5 defi  ciency  also 
leads to accumulation of internalized/undigested TGFβ recep-
tors within the lumen, as well as on the limiting membrane of 
LAMP1-positive endosomes/MVBs, after TGFβ stimulation. 
Consistent with our data, a recent study has also shown that a 
putative CHMP5-negative mutant, or a CHMP5 depletion using 
siRNA, perturbed the distribution of EGFR-containing late 
  endosomes and EGFR traffi  cking, resulting in the accumulation 
of EGFR in enlarged perinuclear vesicles. In addition, loss of 
CHMP5 stabilized ligand-bound EGFR and increased its half-
life by twofold (Ward et al., 2005). Thus, CHMP5 plays an 
  essential role in traffi  cking and degradation of growth factor 
 receptors,  including  TβRII and EGFR. Given that CHMP5 
functions downstream of Hrs and TSG101 in endocytosis, and 
that much of the HA-TβRII in late endosomes/MVBs was 
  protected from extravesicular proteinase K digestion, it seems 
likely that in CHMP5-defi  cient cells MVB sorting of internal-
ized TGFβ receptors by Hrs/TSG101 and invagination of internal 
vesicles is normal. This would suggest that the MVBs to which 
the internalized receptors are delivered were rendered cataboli-
cally defective, secondary to a block in the fusion of lysosomes 
with MVBs or in the maturation of MVBs into lysosomes. Thus, 
in mammalian cells, the ESCRT-III complex member CHMP5 
may not be required for MVB formation or cargo selection. 
  Instead, it appears to control a late step in lysosomal biogenesis 
required for the transfer of internalized material to a hydrolyti-
cally active compartment, one that plays a critical role in down-
regulation of signaling pathways through receptor degradation.
Materials and methods
Cells and reagents
NIH3T3 (murine ﬁ   broblast cells) and NMuMG (mammary gland cells; 
CRL-1636) cell lines were purchased from the American Type Culture 
  Collection. The antibodies used were anti–phospho-Erk1/2 (Cell Signaling 
Technology), anti–phospho-Smad2 (Cell Signaling Technology), anti-Smad4 
(Santa Cruz Biotechnology, Inc; H552), anti-Smad2 (Cell Signaling Tech-
nology), anti-M6PR (Afﬁ  nity BioReagents, Inc.), anti-EEA1 (BD Biosciences), 
anti-TGN38 (BD Biosciences), anti–mouse transferrin receptor (BD Biosci-
ences; C2), anti–mouse LAMP1 (BD Biosciences; ID4B), and anti-GAPDH4 
(Fitzgerald Industries International). An anti-CHMP5 polyclonal antibody 
was generated by immunizing rabbits with a 17-aa synthetic peptide corre-
sponding to the COOH-terminal sequence of mouse CHMP5 and afﬁ  nity 
puriﬁ  ed with immobilized antigen. Antibodies speciﬁ  c to LBPA, Rab8, and 
MHC II (I-Aβ) were gifts from T. Kobayashi (Institute of Physical and Chemical 
Research, Wako, Saitama, Japan) and I. Mellman (Yale University School 
of Medicine, New Haven, CT). Plasmids encoding HA-TBI and HA-TBII 
were a gift from J.L. Wrana (University of Toronto, Toronto, Canada).CHMP5 IS ESSENTIAL FOR LATE ENDOCYTIC TRAFFICKING • SHIM ET AL. 1055
Cloning of Chmp5
CHMP5 was copuriﬁ   ed with IκBα from rabbit lung tissue extract. After 
  separation on SDS-PAGE and silver staining, a 32-kD band was excised 
from the gel and trypsinized, and ﬁ   ve peptides were microsequenced. 
One mouse EST (available from GenBank/EMBL/DDBJ under accession 
no.  <GENBANK>W51061 </GENBANK>) matched these peptides and was used as a probe to screen 
a mouse liver cDNA library. One clone containing the Chmp5 open reading 
frame was obtained and an additional 5′   sequence was cloned by 5′ 
rapid ampliﬁ  cation of cDNA ends.
Generation of Chmp5
+/− mice and Chmp5
−/− ES cells
Four Chmp5 genomic clones were isolated from a 129/SvJ mouse genomic 
DNA library (Stratagene). The targeting vector consists of a 5.3-kb 5′ homol-
ogy region and a 4.7-kb 3′ homology region. A loxP-PGKneo-loxP cassette 
was inserted between the two regions and a PGK-TK cassette was placed 
  upstream of the 5′ homology region, resulting in a vector designed to delete 
  exons 3–7 of Chmp5. Linearized targeting vector was electroporated into 
TC1 ES cells. Clones resistant to G418 and gancyclovir were selected, and 
homologous recombination was conﬁ   rmed by Southern blotting. Two tar-
geted clones were injected into C57BL/6 blastocysts and both produced 
germline chimeras. Chimeras were mated with C57BL/6 females, and 
  heterozygous male offspring were bred with female splicer mice to delete the 
ﬂ  oxed neo cassette. Their offspring were screened for the targeted allele with-
out the neo cassette and in the absence of the cre transgene. Positive mice 
were interbred and maintained on a mixed 129 × C57BL/6 background.
To establish Chmp5
−/− ES cell lines, Chmp5
+/− mice were mated, 
blastocysts were collected, and ES cell lines were isolated from the inner 
cell mass and cultured as previously described (Robertson, 1987). 
The   genotypes of ES cell lines were determined by Southern blotting and 
immunoblotting with anti-CHMP5 antibody.
Whole-mount in situ hybridization and TUNEL assay
Whole-mount TUNEL assay and in situ hybridization using digoxigenin 
UTP-labeled riboprobes were performed as previously described (Sasaki 
and Hogan, 1993). Embryos were placed on 60-mm Petri dish containing 
1% agarose that was ﬁ   lled with PBS and oriented as indicated. The
  embryos were imaged on a dissecting microscope (model Stemi 2000-C; 
Carl Zeiss MicroImaging, Inc.) using 16×/16, NA 2.5, objectives 
  (AxioCam; Carl Zeiss MicroImaging, Inc.). Image data was acquired and 
stored as TIFF ﬁ  les using AxioCam software.
Isolation of cells from mouse embryos
E8.5 embryos from breeding of Chmp5
+/− mice were dissected free of 
maternal tissues and had their Reichert’s membrane removed, after which 
they were washed with PBS and incubated with 0.1% collagenase (Sigma-
Aldrich) and Trypsin-EDTA (Invitrogen) for 30 min at 37°C. The cell sus-
pension was plated in 24-well plates precoated with 0.2% gelatin 
(Sigma-Aldrich) and cultured in DME supplemented with 15% FBS (Sigma-
Aldrich). Chmp5
−/− cells were identiﬁ  ed by immunostaining with CHMP5 
antibody or PCR from extraembryonic tissues.
Transmission electron microscopy
E8.0–8.25 embryos were dissected and washed with PBS, and then ﬁ  xed 
with 4% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium 
  cacodylate buffer, pH 7.2, for 1 h at room temperature. Further procedures 
were performed by standard protocols.
Immunoﬂ  uorescence
For immunoﬂ  uorescence analysis, cells were grown on 0.2% gelatin-coated 
coverslips, washed with PBS, ﬁ  xed with 4% paraformaldehyde for 30 min 
at room temperature, and permeabilized with permeabilization buffer 
(0.05% saponin, 1% FBS, 10 mM Hepes, and 10 mM glycine in PBS, pH 
7.5) for 30 min at room temperature. Cells were incubated with the 
  indicated primary antibodies for 30 min at room temperature and then 
  incubated with either goat anti–rabbit or anti–mouse antibodies conju-
gated with FITC or Texas red under identical conditions. Subsequently, cells 
were washed three times with PBS, mounted in GEL/MOUNT (Biomeda), 
and examined under either a Plan Apochromat 63× oil objective or a Plan 
Neoﬂ  uar 40× oil objective on a ﬂ  uorescence microscope (Axioplan 2; all 
Carl Zeiss MicroImaging, Inc.) equipped with a charge-coupled device 
camera (Orca ER; Hamamatsu). Image data was acquired and stored as 
TIFF ﬁ  les using OpenLab software (Improvision, Inc.).
Generation of CHMP5 ShRNAs
shRNAs with murine CHMP5 target sequence Sh2 (5′-C  C  T  G  G  C  C  C  A  A-
C  A  G  T  C  C  T  T  T  -3′) and murine CHMP5 control sequence Sh1 (5′-A  A  G  C-
G  A  A  A  C  C  C  A  A  G  G  C  T  C  C  -3′), or human CHMP5 target sequence Sh3 
(5′-A  A  G  G  A  C  A  C  C  A  A  G  A  C  C  A  C  G  G  T  T  -3′) were produced by chemically 
synthesized DNA oligonucleotides and cloned into pSUPER.retro vector 
following the manufacturer’s instruction (OligoEngine). To test ShRNAs, 
Flag-tagged Chmp5 cDNA and CHMP5 ShRNAs were cotransfected into 
COS1 cells. 48 h after transfection, cells were lysed and immunoblotted 
with antibodies speciﬁ  c for Flag and GAPDH4.
Endosome–lysosome transport assay
NIH3T3 cells were cultured in medium containing protease inhibitors to 
  inhibit protein degradation in lysosomes throughout the experiment. Cells 
were incubated with biotin-conjugated HRP for 3 h to label lysosomes 
  before being transfected with CHMP5 shRNA. 48 h after transfection, cells 
were incubated with streptavidin for 10 min, washed, chased for the indi-
cated time points, and lysed with biotin-containing lysis buffer. Lysates 
were applied to antistreptavidin-coated plates, incubated for 1 h, and 
washed; HRP enzymatic activity was measured by colorimetric assay and 
is expressed as arbitrary units.
Subcellular fractionation and protease protection assay
HEK293 cells were transfected with COOH-terminal HA-TβRII in the pres-
ence or absence of human CHMP5 shRNA (Sh3). 48 h after transfection, 
cells were treated with 10 ng/ml TGFβ for 5 h or left untreated and fraction-
ated using Percoll gradients as previously described (Marsh et al., 1987). 
In brief, cells were washed and resuspended in homogenization buffer 
(10 mM triethanolamine, 10 mM acetic acid, 1 mM EDTA, and 0.25 M 
sucrose, pH 7.4) and disrupted with 20 strokes in a dounce homogenizer. 
Microscopic analysis assured that the cell breakage was nearly complete. 
The homogenate was centrifuged at 1,000 g for 5 min at 4°C to remove nu-
clei and unbroken cells. The postnuclear supernatant was mixed with   Percoll 
(Sigma-Aldrich) in homogenization buffer to give a ﬁ  nal concentration of 
27%, and the mixture was underlaid with a 27.6% nycodenz solution (Sigma-
Aldrich). The gradients were centrifuged in a SW41Ti rotor at 17,500 rpm 
for 1 h at 4°C, and 14 fractions were collected from the top of gradient.
Protease protection assays have traditionally been used to determine 
the sidedness of proteins relative to a sealed membrane compartments 
(Blobel and Sabatini, 1970; Sabatini and Blobel, 1970). These experi-
ments typically involve the complete digestion of exposed domains of 
  proteins on the outside of a sealed compartment and the protection of those 
domains or proteins that reside on the inside of the compartment (Wu et al., 
2003; Sik et al., 2004). To apply the protease protection   assay to our 
  system, we modiﬁ  ed the original protocol of the protease protection assay. 
For protease protection assay, 25-μl aliquots of each fraction were treated 
with 2–5 μg proteinase K for 30 min at room   temperature or left untreated. 
The reaction was stopped by adding SDS loading buffer, and proteinase K 
was inactivated by boiling at 90°C. The samples were subjected to 10% 
SDS-PAGE, followed by immunoblotting with the indicated antibodies.
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